PATENT CLAIM ANALYSIS

Application Number: 15890990
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "047000"]

Abstract:
2′ and/or 3′ prodrugs of 1′, 2′, 3′ or 4′-branchednucleosides, and their pharmaceutically acceptable salts and derivatives are described. These prodrugs are useful in the prevention and treatment of Flaviviridae infections, including HCV infection, and other related conditions. Compounds and compositions of the prodrugs of the present invention are described. Methods and uses are also provided that include the administration of an effective amount of the prodrugs of the present invention, or their pharmaceutically acceptable salts or derivatives. These drugs may optionally be administered in combination or alteration with further anti-viral agents to prevent or treat Flaviviridae infections and other related conditions.

Claim (Index 8):
The method of  claim 7 , wherein the second anti-viral agent is an interferon.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 88.0
- Lexical Diversity: 1.88333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13168895', '11005473', '10261244', '11005447', '10715729']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7912989797788272
- 35 USC 102 Novelty (BERT): 0.5599471019437784
- Combined Prediction Score: 0.7681637919953224
- Mean Citation Score: 378.14248
- Max Citation Score: 446.71884000000006
- Similarity Product: 310.29228462296965

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test